Form D · Pharmaceuticals
PALKION INC
San Diego, CA · CIK 0001429487
Offering snapshot reported Oct 19, 2010 · SEC filing
- Reported sold
- $1.75M Offering amount: $1.75M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 27, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 19, 2010 | Initial | $1,750,000 | No comparison | 1 | SEC filing |
| Aug 17, 2009 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Mar 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 10, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-149254
Total Offering Amount and Total Amount Sold is the sum of the second closing and third closing which occurred on February 25, 2010 and October 7, 2010, respectively.
Source: Form D, filed Oct 19, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joong Myung Cho, Ph.D. | Director |
| C. Boyd Clarke | Director |
| Wendy Johnson | Director, Executive |
| Alain B. Schreiber, M.D. | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4365 Executive Drive Suite 1500
San Diego, CA, 92121
San Diego, CA, 92121